Accessibility: Skip TopNav
Figure 1
A single IV dose of ENTR-601-44 resulted in robust exon skipping in both skeletal and cardiac muscles in NHP, as well as prolonged duration of effect for at least 12 weeks
Format
JPEG
Source
Entrada Therapeutics, Inc.
Downloads
Original
Large
Medium
Small